Procurement of Injectable Medications

This tender concerns the procurement of injectable medications, as issued by the State Secretariat of Health (SECRETARIA DE ESTADO DA SAUDE). The contracting authority is seeking to acquire essential pharmaceutical supplies for the ESP-HOSP.EST.ESPEC.REAB.DR.FRANCISCO R.ARANTE facility located in Itu, São Paulo. The procurement process is being conducted through an electronic open bidding modality (Pregão Eletrônico), following the principles of Law 14.133/2021, specifically Article 28, item I, which mandates the bidding modality for the acquisition of common goods and services. The estimated total value for this acquisition is R$ 3,076.51. Interested parties are invited to submit their proposals, with the proposal submission deadline set for March 11, 2026, at 09:00. The proposal opening date is scheduled for February 25, 2026, at 08:00. Further details regarding clarifications and challenges related to this tender document can be accessed via the provided link: https://cnetmobile.estaleiro.serpro.gov.br/comprasnet-web/public/landing?destino=quadro-informativo&compra=09020305900032026. This process, identified by purchase number 90003 and related to process number 024.00003962/2026, aims to ensure the supply of critical injectable medications to the designated healthcare facility.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Brazil, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of BRL 3,077.

Published through Brazil PNCP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.